20059 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Emulsions ; Emulsion preconcentrates; Micelles Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
FORMING A SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM
#302MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY
#303NOVEL FORMULATIONS FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS TO THE GASTROINTESTINAL TRACT
#304CORE-SHELL MICRONEEDLE PATCH FOR H2O2 AND PH CASCADE-TRIGGERED INSULIN DELIVERY
#305COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#306Compositions and methods for delivery of RNA
#307MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY
#308Nimodipine Parenteral Administration
#309TES-BASED CATIONIC LIPIDS
#310NEBULIZER AND NEBULIZED ANTI-VIRALS
#311CHEBULINIC ACID AND ITS ENRICHED FRACTION FROM THE FRUITS OF TERMINALIA CHEBULA FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) AND ITS PREPARATION THEREOF
#312STABILIZATION OF VITAMIN A IN A NUTRITIONAL SOLUTION
#313METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES
#314SELF-EMULSIFYING NANO-EMULSIONS
#315MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROME
#316Nanostructured Gels Capable of Controlled Release of Encapsulated Agents
#317CANNABINOID FORMULATIONS AND METHODS OF USE
#318LIVE-ATTENUATED RNA HYBRID VACCINE TECHNOLOGY
#319CANNABINOID EMULSION COMPOSITION AND METHOD OF MANUFACTURING
#320ASYMMETRIC CHARGED VESICLES AND METHODS OF PREPARING AND USE THEREOF
#321MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF
#322HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER
#323Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease
#324Filamentous nanoparticles having vaccine adjuvant effect
#325SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE
#326PHYTONADIONE COMPOSITIONS
#327Method of treatment or alleviating symptoms of a disorder with cannabidiol
#328Ophthalmic formulations and related methods
#329OIL-IN-WATER EMULSIONS FOR INTRAVITREAL ADMINISTRATION
#330HISTIDINE-LYSINE POLYMERS AND METHODS FOR DELIVERING MRNA USING THE SAME
#331CO-LYOPHILIZED RNA AND NANOSTRUCTURED LIPID CARRIER
#332Ophthalmic formulations and related methods
#333SOLID MATERIAL AND DISPERSION COMPOSITION CONTAINING SAME
#334NICOTINAMIDE-ENCAPSULATING MICELLES, AND PREGNANCY-INDUCED HYPERTENSION SYNDROME THERAPY COMPOSITION CONTAINING NICOTINAMIDE-ENCAPSULATING MICELLES
#335MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
#336POLYMERIC CARRIERS FOR DELIVERY OF THERAPEUTIC AGENTS
#337METHOD OF MANUFACTURING MICELLES FOR DRUG DELIVERY
#338POLYMERIC MICELLES COMPRISING GLUCURONIDE-PRODRUGS
#339Targeting Microbubbles
#340SPIROINDOLONE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
#341Artificial Cells and Delivery Devices for Use in Tissue Engineering, and Related Methods
#342PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO
#343NANO-EMULSION OF CBFß-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVER
#344PEPTIDE-NANOPARTICLE CONJUGATES
#345APOTHECARIAL COMPOSITIONS AND RELATED METHODS OF TREATMENT
#346PHARMACEUTICAL COMPOSITIONS FOR IMPROVED DELIVERY OF THERAPEUTIC LIPOPHILIC ACTIVES
#347MICROEMULSION DRUG DELIVERY SYSTEM FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
#348PROTECTIVE FORMULATIONS
#349BIOLOGICALLY ACTIVE ADDITIVE BASED ON MESOPOROUS SILICON DIOXIDE AND ON MICELLAR SOLUTIONS OF ACTIVE SUBSTRATES AND METHOD FOR PREPARING SAME
#350Limit size lipid nanoparticles and related methods
#351PHARMACEUTICAL COMPOSITIONS FOR TREATING INFECTIONS BY A NEUROTROPIC VIRUS
#352Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation method thereof and use thereof as anticancer agent or antiviral agent comprising the same
#353COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES
#354ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING LIPID CONJUGATES
#355METHOD OF USING HIGH-FREQUENCY SOUND WAVES
#356ISOTONIC LIPID EMULSION
#357RAPAMYCIN (RAPA) SELF-MICROEMULSIFYING INJECTION AND PREPARATION METHOD AND USE THEREOF
#358MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#359Formulation of a peptide vaccine
#360Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
#361Formulation Comprising a Proteinaceous Microgel
#362SURFACTANT COMPOSITIONS AND METHODS FOR EMULSIFYING CANNABINOID EXTRACTS AS A NANO-EMULSION MATERIAL
#363Compositions and methods for deep dermal drug delivery
#364TOPICAL PHARMACEUTICAL COMPOSITIONS
#365Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
#366ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS
#367EMBOLIZING AGENT PRECURSOR PHARMACEUTICAL COMPOSITION
#368METHOD OF IMAGING
#369COMPOSITION CONTAINING CANNABINOIDS
#370Natural Combination Hormone Replacement Formulations and Therapies
#371COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF
#372COLD FILTRATION OF OIL-IN-WATER EMULSION ADJUVANTS
#373Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS)
#374Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents
#375DELIVERY OF GENE EXPRESSION MODULATING AGENTS FOR THERAPY AGAINST CANCER AND VIRAL INFECTION
#376TREATMENT OF INFECTIONS
#377METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC CANNABINOIDS
#378PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY
#379OPHTHALMIC NANOEMULSION COMPOSITIONS
#380FORUMULATION OF MONODISPERSE KINETICALLY FROZEN POLYMER MICELLES VIA EQUILIBRATION-NANOPRECIPITATION
#381NANOSYSTEMS AS SELECTIVE VEHICLES
#382STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN INJURY
#383Methods for Reduction of Body Weight with Subcutaneous Formulations
#384OIL-IN-WATER EMULSIONS COMPRISING CETALKONIUM CHLORIDE AND METHODS OF MAKING AND USING THE SAME
#385Abiraterone acetate containing composition and application thereof
#386COMPOSITIONS FOR DELIVERY OF BIOACTIVE AGENTS INTO HAIR FOLLICLES
#387ENCAPSULATED COMPOSITIONS AND USE OF OCTENYLSUCCINIC ANHYDRIDE STARCH AS EMULSIFYING AGENT
#388CANNABIDIOL ORALLY DISINTEGRATING TABLETS
#389PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#390OMEGA FATTY ACIDS-RICH OIL DISPERSION FORMULATIONS
#391WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDS
#392OPHTHALMIC FORMULATION AND ITS USE
#393COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES
#394LIPID EMULSIONS AND USES THEREOF
#395RIBONUCLEASES FOR TREATING VIRAL INFECTIONS
#396MICELLAR DISINFECTANTS
#397TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
#398OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME
#399O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#400POLYMER LUNG SURFACTANTS
#401FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF
#402ADMINISTRATION OF mTOR INHIBITORS INTO THE CENTRAL NERVOUS SYSTEM
#403GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#404Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof
#405TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
#406Microemulsion Delivery Systems for Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms
#407Transdermal carrier
#408DIAGNOSTIC METHODS USING PCG-1A EXPRESSION
#409Electronic devices and liquids for aerosolizing and inhaling therewith
#410Compositions and methods for delivery of RNA
#411DIAGNOSTIC METHODS USING SIRT1 EXPRESSION
#412APPLICATION OF FULLERENE AND DERIVATIVES THEREOF IN REGULATING INTESTINAL FLORA
#413Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones
#414ECHOGENIC COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PAIN
#415EDB-FN AS BIOMARKER OF CANCER AND/OR BRAIN DISEASE AND NANODRUG DELIVERY SYSTEM TARGETING SAME
#416ZWITTERIONIC POLYPEPTIDE AND DERIVATIVE THEREOF AND NANODRUG BASED THEREON
#417POLY(BETA-AMINO ESTER)-CO-POLYETHYLENE GLYCOL (PEG-PBAE-PEG) POLYMERS FOR GENE AND DRUG DELIVERY
#418Compositions and methods for delivery of RNA
#419Process for producing an andrographolide carrier system
#420Methods and products for treating subjects with autism spectrum disorders
#421MEDICAL USE OF ICARITIN
#422NANOMETRIC PHARMACEUTICAL COMPOSITION IN THE FORM OF LIPOSOMES OR NANOEMULSION CONTAINING SPECIFIC SEQUENCES OF INTERFERENCE RNA
#423Full spectrum hemp oil compositions
#424NANOEMULSION COMPOSITIONS COMPRISING BIOLOGICALLY ACTIVE INGREDIENTS
#425In-situ Gel Containing Cyclosporine Micelles as Sustained Ophthalmic Drug Delivery System
#426Compositions and methods for delivery of RNA
#427AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS
#428MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF
#429Block copolymer and micelle compositions and methods of use thereof
#430Combination taxoid nanoemulsion with immunotherapy in cancer
#431MICELLAR COMPOSITION FROM AN AMPHIPHILIC COPOLYMER FOR TUMOR THERAPY
#432Pharmaceutical compositions containing mixed polymeric micelles
#433System and Method for Making Cannabinoid Nanoparticle Carrier Composition
#434Methods of use of emulsion formulations of an NK-1 receptor antagonist
#435NANOFORMULATIONS OF METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3 -YL]PYRIMIDIN-5-YL} CARBAMATE
#436Astaxanthin nanoemulsion and manufacturing method thereof
#437METHODS FOR PRODUCING OIL-IN-WATER EMULSIONS
#438Mechano-sensitive microcapsules for drug delivery
#439Multisomes: encapsulated droplet networks
#440ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY
#441Micelle preparations of full-spectrum hemp oil
#442METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#443ACTIVE INGREDIENT-CONTAINING NANOEMULSIONS
#444BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF
#445Oxygen gas sustained released nano-emulsion composition and method for producing the same
#446MODULAR DENDRON MICELLES FOR TREATMENT OF PULMONARY DISEASES RELATED TO FIBROSIS AND VIRAL INFECTION INCLUDING COVID-19
#447CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING SAME
#448Nano-emulsion composition for tooth whitening and method for producing the same
#449Compositions and methods for delivery of RNA
#450COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#451RIG-I AGONIST AND ADJUVANT FORMULATION FOR TUMOR TREATMENT
#452NANOEMULSION COMPOSITIONS FOR TREATING AEROALLERGEN ASSOCIATED ALLERGY AND INFLAMMATION
#453NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
#454Compositions and methods for delivery of RNA
#455TREATMENT OF PANCREATIC CANCER
#456SELF-EMULSIFYING CANNABINOID FORMULATION AND METHOD
#457LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF
#458Compositions and methods for nasal administration of drugs to brain and for systemic effect
#459PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF
#460WATER-DISPERSIBLE CANNABIDIOL PRODUCT AND PREPARATION METHOD THEREFOR
#461LIPIDATED POLY(AMINO ACID) NANOSTRUCTURES
#462BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#463PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS
#464Immune stimulating micelle composition
#465OPHTHALMIC PHARMACEUTICAL COMPOSITION, PREPARATION METHODS AND USES OF THE SAME
#466MEDICATED DRINK
#467ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE
#468BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF
#469ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE SALT BLEND AND RELATED COMPOUNDS IN HUMANS
#470POMEGRANATE OIL FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES
#471TEMPERATURE-RESPONSIVE DRUG/POLYMER COMPOUND AND APPLICATION OF COMPOUND TO DRUG DELIVERY
#472Polymeric micelle, methods of production and uses thereof
#473CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME
#474Nucleic acid-small diameter and liquid core nanoparticle complexed compositions
#475Biotherapy for viral infections using biopolymer based micro/nanogels
#476COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS
#477Mitochondrial performance enhancement nanoemulsion method
#478Core-satellite micelle including tetra-block copolymer and preparation method thereof
#479NANOEMULSION OF 18BETA-GLYCYRRHETINIC ACID
#480Composition and Method of Preparation for Lipid Formulations Comprising Charged Lipids
#481Microemulsion mixture and method of using the same, and pharmaceutical microemulsion mixture and method of using the same
#482CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND DRUG-LOADED IMPLANTABLE MEDICAL DEVICE
#483COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE
#484FLAVONOIDS AND LINOLEIC ACID USES IN HYPERTENSION
#485Phenyl containing compound, intermediate thereof, preparation method therefor and application thereof
#486CONTINUOUS METHOD FOR NANO-EMULSIFICATION BY CONCENTRATION PHASE INVERSION
#487HYDROPHOBICALLY ASSOCIATING POLYMER COUNTER ION PAIR COMPLEXES
#488Liver activation nanoemulsion and toxin excretion enhancement method
#489NANO-DISPERSION METHODS FOR CANNABIS EXTRACT
#490PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUND
#491THERMOGELLING NANOEMULSIONS FOR PHARMACEUTICAL MANUFACTURING
#492MICELLAR NANOPARTICLES AND USES THEREOF
#493POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR
#494Compositions for Nanoemulsion Delivery Systems
#495Compositions and methods for delivery of RNA
#496Compositions and methods for delivery of RNA-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
#497Surfactant microbubbles compositions and process for preparing thereof
#498SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL
#499Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell
#500Extended Release Vitamin C and Manufacturing Thereof
#501NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#502STABILISATION AND CONTROLLED-RELEASE SYSTEMS FOR MEDICAMENTS UNSTABLE ON STERILISATION
#503Conditioning irradiated tissue for increasing vascularity
#504COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF
#505Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones
#506COMPOSITIONS AND METHODS FOR SUSTAINED TREATMENT OF PAIN
#507CANNABINOID EMULSION COMPOSITION AND METHOD OF MANUFACTURE
#508Microemulsion Delivery Systems for Water-Based Beverages
#509ORAL ADMINISTRATION OF UNSTABLE OR POORLY-ABSORBED DRUGS
#510POLYMER-LIPID NANOCOMPLEX FOR ENHANCED AQUEOUS SOLUBILISATION AND ABSORPTION OF HYDROPHOBIC ACTIVE COMPOUNDS
#511MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES
#512NANO- OR MICRO-EMULSION COMPOSITIONS AND METHODS OF USE THEREOF
#513pH RESPONSIVE COMPOSITIONS AND USES THEREOF
#514COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#515GLP-1 SECRETION-PROMOTING COMPOSITION
#516ORALLY ADMINISTRABLE COMPOSITION
#517POLYMERIC MICELLE COMPLEXES, FORMULATIONS, AND USES THEREOF
#518TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES
#519TRANSDERMAL DELIVERY OF LARGE AGENTS
#520INJECTABLE POLYMER NANOPARTICLE COMPOSITIONS OF ANTITHROMBOTIC AGENTS AND METHODS THEREOF
#521SELF-EMULSIFYING DRUG DELIVERY (SEDDS) FOR OPHTHALMIC DRUG DELIVERY
#522Nanoparticle to target cancer
#523NANO CO-DELIVERY OF QUERCETIN AND ALANTOLACTONE PROMOTES ANTI-TUMOR RESPONSE THROUGH SYNERGISTIC IMMUNOGENIC CELL DEATH FOR MICROSATELLITE-STABLE COLORECTAL CANCER
#524Water soluble compositions and methods of making the same
#525ADMINISTRATION OF BERBERINE METABOLITES
#526Curcumin Solubilisate
#527SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS
#528NANO-PUERARIN REGULATES TUMOR MICROENVIRONMENT AND FACILITATES CHEMO- AND IMMUNOTHERAPY IN MURINE TRIPLE NEGATIVE BREAST CANCER MODEL
#529BIOACCESSIBILE COMPOSITIONS OF LIPOPHILIC COMPOUNDS AND PROCESS THEREOF
#530CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#531NANOEMULSION HYDROPHOBIC SUBSTANCES
#532METHOD FOR PREPARING EYE DROPS OF CYCLOSPORIN A
#533BLOCK COPOLYMERS AND USES THEREOF
#534A Product and Process For A Room-Temperature Stable, Food-Grade, All-Natural, Vegan, And Phyto-Cannabinoid/Terpene/Flavonoid Colloidal Dispersion
#535PROCESS FOR PRODUCTION OF A NANO-MICROEMULSION SYSTEM OF FERULIC
#536Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof
#537GLUCOSE-RESPONSIVE INSULIN DELIVERY MICRONEEDLE SYSTEM
#538TUMESCENT INFILTRATION DRUG DELIVERY OF CANNABINOIDS
#539Non-ionic PVP-PLA block copolymers and liquid pharmaceutical compositions derived therefrom
#540BROAD-BASED THERAPEUTIC FOR INACTIVATING COVID-19 AND OTHER VIRAL PATHOGENS USING CHEMILUMINESCENCE-ACTIVATED COMPOUNDS ENCAPSULATED IN NANOPARTICLES
#541Modular metal-organic polyhedra superassembly compositions
#542ANTIVIRAL COMPOSITION AND USE OF THE SAME
#543Topical treatment of wounds with statins and cholesterol for scar reduction
#544COMPOSITIONS AND METHODS FOR INDUCING ANTIGEN-SPECIFIC TOLERANCE
#545PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR
#546Solubilizate with curcumin and optionally at least one other active substance
#547Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
#548CANNABINOID EMULSIONS
#549Method for preparing stable liquid emulsion forms of plant extract
#550Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
#551Branched peptides for enzymatic assembly and mitochondria drug delivery
#552METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES
#553HERPES SIMPLEX VIRUS NANOEMULSION VACCINES AND METHODS OF USING THE SAME
#554Micellar nanoparticles and uses thereof
#555Nano-carrier topical composition with vitamin D3
#556AMPHIPHILIC BLOCK COPOLYMER, PREPARATION METHOD THEREOF AND NANOMICELLE DRUG-LOADING SYSTEM
#557RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region
#558Compositions and methods for delivery of RNA
#559Targeting microbubbles
#560COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER
#561Orally Administrable Composition
#562Polyvalent sting activating compositions and uses thereof
#563Therapeutic Medical Device and Methods of Use
#564TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY
#565Formulation comprising water soluble particles of a non-curcuminoid and a curcuminoid
#566Nanostructured lipid carriers and stable emulsions and uses thereof
#567Method for making reduction sensitive nano micelles
#568Nanoemulsion Compositions Comprising Saponins for Increasing Bioavailability
#569BOTULINUM NANOEMULSIONS
#570Dual-drug co-delivery system, preparation method therefor and use thereof
#571Administration of berberine metabolites
#572Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals
#573NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES
#574Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
#575STABLE FORMULATIONS OF ANESTHETICS AND ASSOCIATED DOSAGE FORMS
#576VITAMIN D MICRO-EMULSIOINS AND USES THEREOF
#577TOPICAL AND TRANSDERMAL DELIVERY OF HIF-1 MODULATORS TO PREVENT AND TREAT CHRONIC WOUNDS
#578TOPICAL COMPOSITION COMPRISING VIABLE MICROORGANISMS
#579Dilutable formulations of cannabinoids and processes for their preparation
#580Formulations and methods
#581MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT
#582Transdermal carrier
#583Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
#584Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
#585Nanoparticles carrying antibiotics
#586SKIN CRÈME
#587Topical Montelukast formulations
#588NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
#589AROMATIC RING SUBSTITUTED AMPHIPHILIC POLYMERS AS DRUG DELIVERY SYSTEMS
#590PROCESS FOR PRODUCING A NANO-TAN IIA MICROEMULSION SYSTEM
#591Phospholipid-Free Small Unilamellar Vesicles (PFSUVS) for Drug Delivery
#592Methods of imaging and delivering therapeutic agents
#593DIRECT NANOEMULSION PROCESS FOR THE SYNTHESIS OF SPHEROIDAL ORGANOSILOXANE SUB-MICRON/NANOPARTICLES
#594NOVEL FORMULATIONS AND METHODS FOR TREATING DERMATOLOGICAL DISORDERS OR DISEASES
#595Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
#596OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#597Ascorbic acid formulation
#598CARMUSTINE FORMULATION
#599NANOEMULSION CANNABIS FORMULATIONS AND METHODS OF MAKING SAME
#600Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents